Individuals' behavior costs USA $163 billion annually in pharmacy-related waste

23 April 2010

US pharmacy benefits firm Express Scripts says it is the first organization ever to quantify the hidden health care costs of very common behaviors related to prescription drugs, such as forgetfulness and procrastination, estimating the annual wasteful spending in the USA at $163 billion.

The Express Scripts 2009 Drug Trend Report released this week quantifies changes in drug spend on a year-to-year basis and details the costly effects of irrational behaviors on pharmacy-related costs.

"The good news is that these potential savings in the pharmacy benefit are tied to one of the few variables in health care we can readily influence: behaviour. This research shows that in terms of achieving lower costs and improved outcomes, health care reform starts in the home," said Steven Miller, senior vice president and chief medical officer at Express Scripts.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics